2-氯-6-甲基烟酰氯 | 39853-81-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 2-氯-6-甲基烟酰氯
• 中文别名: 2-氯-6-甲基-3-吡啶甲酰氯
• 英文名称: 2-chloro-6-methyl-nicotinic acid chloride
• 英文别名: 2-chloro-6-methylnicotinoyl chloride；2-Chlor-6-methylpyridin-3-carbonsaeurechlorid；6-methyl-2-chloronicotinoyl chloride；2-chloro-6-methylnictotinyl chloride；2-chloro-6-methylpyridine-3-carbonyl chloride
• CAS: 39853-81-1
• 化学式: C₇H₅Cl₂NO
• mdl: MFCD09953461
• 分子量: 190.029
• InChiKey: ZDWXDEDBIUIQMY-UHFFFAOYSA-N

物化性质

• 沸点：
  277℃
• 密度：
  1.384
• 闪点：
  121℃

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  30
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  8
• 海关编码：
  2933399090
• 包装等级：
  II
• 危险品运输编号：
  UN3265

反应信息

• 作为反应物：
  描述：

  2-氯-6-甲基烟酰氯 在 ammonium hydroxide 、 sodium hydroxide 、 溴 作用下， 以 氯仿 为溶剂， 反应 1.0h， 生成 6-甲基-3-氨基-2-氯吡啶
  参考文献：
  名称：

  2-Phenyl-3H-imidazo[4,5-b]pyridine-3-acetamides as nonbenzodiazepine anticonvulsants and anxiolytics

  摘要：

  A series of 2-phenyl-3H-imidazo[4,5-b]pyridine-3-acetamides were designed and synthesized as non-benzodiazepine anxiolytics based on a molecular disconnection of a typical 1,4-benzodiazepine (BZD). A number of these compounds showed submicromolar potency in a [H-3]benzodiazepine binding assay in vitro and good potency in protecting rodents against pentylenetetrazole-induced seizures. Compound 84 appears to be a selective anticonvulsant (pentylenetetrazole) agent when tested against a profile of chemically and electrically induced seizures in mice. In addition, compound 148 appears to be a selective anxiolytic/hypnotic agent on the basis of biochemical and pharmacological characterization. It appears to be a full BZD agonist as assessed by GABA shift ratio and to be effective in punishment and nonpunishment animal models of anxiety. In addition, it shows a lower side-effect profile than diazepam as assessed by rotorod neurotoxicity and potentiation of ethanol-induced sleep time in mice. The chemistry and structure-activity relationships of this series is discussed.

  DOI：

  10.1021/jm00114a007
• 作为产物：
  描述：

  2-羟基-6-甲基烟酸 在 五氯化磷 、 三氯氧磷 作用下， 反应 3.0h， 生成 2-氯-6-甲基烟酰氯
  参考文献：
  名称：

  2-Phenyl-3H-imidazo[4,5-b]pyridine-3-acetamides as nonbenzodiazepine anticonvulsants and anxiolytics

  摘要：

  A series of 2-phenyl-3H-imidazo[4,5-b]pyridine-3-acetamides were designed and synthesized as non-benzodiazepine anxiolytics based on a molecular disconnection of a typical 1,4-benzodiazepine (BZD). A number of these compounds showed submicromolar potency in a [H-3]benzodiazepine binding assay in vitro and good potency in protecting rodents against pentylenetetrazole-induced seizures. Compound 84 appears to be a selective anticonvulsant (pentylenetetrazole) agent when tested against a profile of chemically and electrically induced seizures in mice. In addition, compound 148 appears to be a selective anxiolytic/hypnotic agent on the basis of biochemical and pharmacological characterization. It appears to be a full BZD agonist as assessed by GABA shift ratio and to be effective in punishment and nonpunishment animal models of anxiety. In addition, it shows a lower side-effect profile than diazepam as assessed by rotorod neurotoxicity and potentiation of ethanol-induced sleep time in mice. The chemistry and structure-activity relationships of this series is discussed.

  DOI：

  10.1021/jm00114a007

文献信息

• Method of inhibiting angiogenesis
  申请人：——

  公开号：US20040067985A1

  公开（公告）日：2004-04-08

  Compounds having the formula 1 are angiogenesis inhibitors. Also disclosed are compositions containing the compounds, methods of making the compounds, and methods of treatment using the compounds.

  具有以下化学式的化合物是抑制血管生成的抑制剂。还公开了含有这些化合物的组合物、制备这些化合物的方法以及使用这些化合物进行治疗的方法。
• [EN] INDOLYLMETHYL-MORPHOLINE DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DERIVES D'INDOLYLMETHYL-MORPHOLINE EN TANT QU'INHIBITEURS DES KINASES
  申请人：UCB PHARMA SA

  公开号：WO2010146351A1

  公开（公告）日：2010-12-23

  A series of morpholine derivatives, substituted in the 4-position by a substituted carbonyl or sulfonyl moiety, and in the 3-position by an optionally substituted indol-3-ylmethyl group, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.

  一系列在4-位置被取代的吗啉衍生物，通过取代的羰基或磺酰基团取代，并在3-位置通过一个可选择取代的吲哚-3-基甲基基团，作为选择性PI3激酶酶抑制剂，在医学上具有益处，例如在治疗炎症、自身免疫、心血管、神经退行性、代谢、肿瘤、疼痛或眼科疾病方面。
• Discovery of pyrazolo[1,5-a]pyrimidine-3-carbonitrile derivatives as a new class of histone lysine demethylase 4D (KDM4D) inhibitors
  作者：Zhen Fang、Tian-qi Wang、Hui Li、Guo Zhang、Xiao-ai Wu、Li Yang、Yu-lan Peng、Jun Zou、Lin-li Li、Rong Xiang、Sheng-yong Yang

  DOI：10.1016/j.bmcl.2017.05.002

  日期：2017.7

  molecule inhibitors of histone lysine demethylase 4D (KDM4D). Molecular docking was first performed to screen for new KDM4D inhibitors from various chemical databases. Two hit compounds were retrieved. Further structural optimization and structure-activity relationship (SAR) analysis were carried out to the more selective one, compound 2, which led to the discovery of several new KDM4D inhibitors. Among

  在本文中，我们报道了一系列新的组蛋白赖氨酸脱甲基酶4D（KDM4D）小分子抑制剂的发现。首先进行分子对接以从各种化学数据库中筛选出新的KDM4D抑制剂。检索到两个命中化合物。对选择性更高的化合物2进行了进一步的结构优化和结构-活性关系（SAR）分析，这导致了几种新型KDM4D抑制剂的发现。其中，化合物10r是最有效的化合物，其对KDM4D的IC 50值为0.41±0.03μM。总体而言，化合物10r可作为进一步研究的良好先导化合物。
• [EN] BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS<br/>[FR] PETITES MOLÉCULES CONTENANT DU BORE ET UTILISABLES EN TANT QU'AGENTS ANTIPROTOZOAIRES
  申请人：ANACOR PHARMACEUTICALS INC

  公开号：WO2011019618A1

  公开（公告）日：2011-02-17

  This invention provides, among other things, novel compounds useful for treating protozoal infections, pharmaceutical compositions containing such compounds, as well as combinations of these compounds with at least one additional therapeutically effective agent. The compounds have the following formula: wherein X is selected from the group consisting of substituted phenyl, substituted or unsubstituted heteroaryl and unsubstituted cycloalkyl; R3a is selected from the group consisting of H1 unsubstituted C1 or C2 or C3 or C4 or C5 or C6 alkyl and unsubstituted C3 or C4 or C5 or C6 cycloalkyl; R3b is selected from the group consisting of H, unsubstituted C1 or C2 or C3 or C4 or C5 or C6 alkyl and unsubstituted C3 or C4 or C5 or C6 cycloalkyl; with the proviso that R3a and R3b, along with the atom to which they are attached, are optionally joined to form a 3 or 4 or 5 or 6 membered ring, with the proviso that R3a and R3b cannot both be H, or a salt thereof.

  这项发明提供了用于治疗原虫感染的新化合物，包含这些化合物的药物组合物，以及这些化合物与至少一种额外治疗有效剂的组合物。这些化合物具有以下结构式：其中X选自取代苯基、取代或未取代杂环芳基和未取代环烷基的组；R3a选自H1未取代的C1或C2或C3或C4或C5或C6烷基和未取代的C3或C4或C5或C6环烷基的组；R3b选自H、未取代的C1或C2或C3或C4或C5或C6烷基和未取代的C3或C4或C5或C6环烷基的组；但R3a和R3b，以及它们连接的原子，可选地结合形成3、4、5或6元环，但R3a和R3b不能同时为H，或其盐。
• A one-pot coupling–addition–cyclocondensation sequence (CACS) to 2-substituted 3-acylpyrroles initiated by a copper-free alkynylation
  作者：Jan Nordmann、Thomas J. J. Müller

  DOI：10.1039/c3ob41269e

  日期：——

  A novel three-component synthesis of 2-substituted 3-acylpyrroles can be initiated by a copper-free Pd-catalyzed alkynylation in a one-pot fashion. The reaction sequence proceeds under mild reaction conditions and in moderate to good yields with a broad scope of diversity.

  2-取代的3-酰基吡咯的新颖的三组分合成可以通过无铜的Pd催化的炔基化反应以一锅法的方式引发。反应顺序在温和的反应条件下进行，并以中等至良好的收率进行，并具有广泛的多样性。